<DOC>
	<DOCNO>NCT02324595</DOCNO>
	<brief_summary>Phase II multicentric study</brief_summary>
	<brief_title>Minimally Invasive Interval Debulking Surgery Ovarian Neoplasm : Feasibility Study</brief_title>
	<detailed_description>The aim prospective Phase II multicentric study assess feasibility early complication rate `` total laparoscopic/robotic '' interval debulking surgery patient clinical complete/partial response neoadjuvant chemotherapy advance ovarian cancer .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year , Advanced ovarian cancer submit neoadjuvant chemotherapy , Clinical serological complete/partial response ( RECIST ; GCIG ) , PS â‰¤ 2 ( ECOG ) , Informed consent Borderline nonepithelial ovarian tumor , Stable/progressive disease , ASA 34 , Severe cardiopulmonary disease , BMI &gt; 40</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Laparoscopy</keyword>
	<keyword>Neoadjuvant Chemotherapy</keyword>
	<keyword>Robotic</keyword>
	<keyword>Interval Debulking Surgery</keyword>
</DOC>